Comments highlight CYP2E1's role in paracetamol metabolism and its hepatotoxic metabolite in varying ages.
A recent article in this journal by Wu et al presented a comprehensive model for the maturation of paracetamol clearance from birth to adulthood using pooled plasma and urinary data of the parent drug and its metabolites from 298 subjects. The modeling showed that the oxidative bioactivation to hepatotoxic metabolite N-acetyl-p-benzoquinone imine (NAPQI) is generally around 10% of the total clearance. We would like to comment on the authors' discussion on the formation of NAPQI, which highlights once again the main role of CYP2E1 in the oxidative bioactivation metabolism of paracetamol. CYP2E1 was demonstrated as a primary catalyst in the bioactivation of paracetamol, referring only to the paper of Johnsrud et al, that describes only the developmental phase of CYP2E1 in man.
No takes yet. Share an insight, caveat, or question.
Pasanen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: